These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8420579)

  • 1. Measures of effect based on the sufficient causes model. 1. Risks and rates of disease associated with a single causative agent.
    Allard R; Boivin JF
    Epidemiology; 1993 Jan; 4(1):37-42. PubMed ID: 8420579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measures of effect based on the sufficient causes model. 2. Risks and rates of disease associated with a single preventive agent.
    Allard R; Boivin JF
    Epidemiology; 1993 Nov; 4(6):517-23. PubMed ID: 8268280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measures of effect based on the sufficient causes model. 3. Multivariate analysis.
    Allard R; Boivin JF; Lepage Y
    Epidemiology; 1997 Jan; 8(1):93-8. PubMed ID: 9116103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the proportion of disease due to classes of sufficient causes.
    Hoffmann K; Heidemann C; Weikert C; Schulze MB; Boeing H
    Am J Epidemiol; 2006 Jan; 163(1):76-83. PubMed ID: 16293718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Completion potentials of sufficient component causes.
    Lee WC
    Epidemiology; 2012 May; 23(3):446-53. PubMed ID: 22450695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White swans, black ravens, and lame ducks: necessary and sufficient causes in epidemiology.
    Pearce N
    Epidemiology; 1990 Jan; 1(1):47-50. PubMed ID: 2081238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A general, multivariate definition of causal effects in epidemiology.
    Flanders WD; Klein M
    Epidemiology; 2015 Jul; 26(4):481-9. PubMed ID: 25946227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AZT does not cause cancer.
    Posit Aware; 1995; ():6. PubMed ID: 11362572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighing the causal pies in case-control studies.
    Liao SF; Lee WC
    Ann Epidemiol; 2010 Jul; 20(7):568-73. PubMed ID: 20538201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenesis theory: a mathematical model relating causal concepts of pathogenesis in individuals to disease patterns in populations.
    Koopman JS; Weed DL
    Am J Epidemiol; 1990 Aug; 132(2):366-90. PubMed ID: 2372013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of synergism in the sufficient-component-cause framework.
    VanderWeele TJ; Robins JM
    Epidemiology; 2007 May; 18(3):329-39. PubMed ID: 17435441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical implications of epidemiological concepts of interaction.
    Pearce N
    Int J Epidemiol; 1989 Dec; 18(4):976-80. PubMed ID: 2621035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using causal models to show the effect of untestable assumptions on effect estimates in randomized controlled trials.
    Allard R; Boivin JF
    Clin Trials; 2007; 4(6):611-20. PubMed ID: 18042570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic assessment of risks of adverse reactions associated with intermittent exposure.
    Feldmann U
    Biometrics; 1993 Jun; 49(2):419-28. PubMed ID: 8369378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
    Cooper DA; Pehrson PO; Pedersen C; Moroni M; Oksenhendler E; Rozenbaum W; Clumeck N; Faber V; Stille W; Hirschel B
    AIDS; 1993 Feb; 7(2):197-207. PubMed ID: 8096703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covariate balance for no confounding in the sufficient-cause model.
    Suzuki E; Tsuda T; Yamamoto E
    Ann Epidemiol; 2018 Jan; 28(1):48-53.e2. PubMed ID: 29241736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.
    Musicco M; Lazzarin A; Nicolosi A; Gasparini M; Costigliola P; Arici C; Saracco A
    Arch Intern Med; 1994 Sep; 154(17):1971-6. PubMed ID: 8074601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Striated nail discoloration caused by zidovudine].
    Bendick C; Rasokat H; Steigleder GK
    Z Hautkr; 1989 Feb; 64(2):91-5. PubMed ID: 2718548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The probability of causation under a stochastic model for individual risk.
    Robins J; Greenland S
    Biometrics; 1989 Dec; 45(4):1125-38. PubMed ID: 2611320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.